Drug Type Small molecule drug |
Synonyms Betamethasone butyrate propionate/maxacalcitol + [4] |
Target |
Mechanism GR agonists(Glucocorticoid receptor agonists), VDR agonists(Vitamin D receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date JP (28 Mar 2016), |
Regulation- |
Molecular FormulaC29H39FO7 |
InChIKeyVXOWJCTXWVWLLC-REGDIAEZSA-N |
CAS Registry5534-02-1 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Psoriasis vulgaris | JP | 22 Nov 2016 | |
Psoriasis | JP | 28 Mar 2016 |